Report for Mathew B

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (23)

Title : Exploiting butyrylcholinesterase inhibitors through a combined 3-D pharmacophore modeling, QSAR, molecular docking, and molecular dynamics investigation - Kumar_2023_RSC.Adv_13_9513
Author(s) : Kumar S , Manoharan A , J J , Abdelgawad MA , Mahdi WA , Alshehri S , Ghoneim MM , Pappachen LK , Zachariah SM , Aneesh TP , Mathew B
Ref : RSC Adv , 13 :9513 , 2023
Abstract : Kumar_2023_RSC.Adv_13_9513
ESTHER : Kumar_2023_RSC.Adv_13_9513
PubMedSearch : Kumar_2023_RSC.Adv_13_9513
PubMedID: 36968055

Title : MAO-B Inhibitor (2E)-3-(4-Bromophenyl)-1-(1H-indol-3-yl) prop-2-en-1-one as a Neuroprotective Agent Against Alzheimer's Disease - Sasidharan_2023_Neurochem.Res__
Author(s) : Sasidharan R , Mohanan R , Kukreti N , Raj P , Abdelgawad MA , Ghoneim MM , Manju SL , Mathew B
Ref : Neurochem Res , : , 2023
Abstract : Sasidharan_2023_Neurochem.Res__
ESTHER : Sasidharan_2023_Neurochem.Res__
PubMedSearch : Sasidharan_2023_Neurochem.Res__
PubMedID: 37814132

Title : Structural Modifications on Chalcone Framework for Developing New Class of Cholinesterase Inhibitors - George_2022_Int.J.Mol.Sci_23_
Author(s) : George G , Koyiparambath VP , Sukumaran S , Nair AS , Pappachan LK , Al-Sehemi AG , Kim H , Mathew B
Ref : Int J Mol Sci , 23 : , 2022
Abstract : George_2022_Int.J.Mol.Sci_23_
ESTHER : George_2022_Int.J.Mol.Sci_23_
PubMedSearch : George_2022_Int.J.Mol.Sci_23_
PubMedID: 35328542

Title : Halogenated Coumarin-Chalcones as Multifunctional Monoamine Oxidase-B and Butyrylcholinesterase Inhibitors - Rehuman_2021_ACS.Omega_6_28182
Author(s) : Rehuman NA , Oh JM , Nath LR , Khames A , Abdelgawad MA , Gambacorta N , Nicolotti O , Jat RK , Kim H , Mathew B
Ref : ACS Omega , 6 :28182 , 2021
Abstract : Rehuman_2021_ACS.Omega_6_28182
ESTHER : Rehuman_2021_ACS.Omega_6_28182
PubMedSearch : Rehuman_2021_ACS.Omega_6_28182
PubMedID: 34723016

Title : Piperazine-substituted chalcones: a new class of MAO-B, AChE, and BACE-1 inhibitors for the treatment of neurological disorders - Mathew_2021_Environ.Sci.Pollut.Res.Int__1
Author(s) : Mathew B , Oh JM , Baty RS , Batiha GE , Parambi DGT , Gambacorta N , Nicolotti O , Kim H
Ref : Environ Sci Pollut Res Int , :1 , 2021
Abstract : Mathew_2021_Environ.Sci.Pollut.Res.Int__1
ESTHER : Mathew_2021_Environ.Sci.Pollut.Res.Int__1
PubMedSearch : Mathew_2021_Environ.Sci.Pollut.Res.Int__1
PubMedID: 33743158

Title : Neuroprotective Effects of Ellagic Acid in Alzheimer's Disease: Focus on Underlying Molecular Mechanisms of Therapeutic Potential - Javaid_2021_Curr.Pharm.Des_27_3591
Author(s) : Javaid N , Shah MA , Rasul A , Chauhdary Z , Saleem U , Khan H , Ahmed N , Uddin MS , Mathew B , Behl T , Blundell R
Ref : Curr Pharm Des , 27 :3591 , 2021
Abstract : Javaid_2021_Curr.Pharm.Des_27_3591
ESTHER : Javaid_2021_Curr.Pharm.Des_27_3591
PubMedSearch : Javaid_2021_Curr.Pharm.Des_27_3591
PubMedID: 33183192

Title : Morpholine-based chalcones as dual-acting monoamine oxidase-B and acetylcholinesterase inhibitors: synthesis and biochemical investigations - Sasidharan_2021_J.Enzyme.Inhib.Med.Chem_36_188
Author(s) : Sasidharan R , Eom BH , Heo JH , Park JE , Abdelgawad MA , Musa A , Gambacorta N , Nicolotti O , Manju SL , Mathew B , Kim H
Ref : J Enzyme Inhib Med Chem , 36 :188 , 2021
Abstract : Sasidharan_2021_J.Enzyme.Inhib.Med.Chem_36_188
ESTHER : Sasidharan_2021_J.Enzyme.Inhib.Med.Chem_36_188
PubMedSearch : Sasidharan_2021_J.Enzyme.Inhib.Med.Chem_36_188
PubMedID: 33430657

Title : Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer's Disease - Uddin_2020_Molecules_25_1267
Author(s) : Uddin MS , Kabir MT , Niaz K , Jeandet P , Clement C , Mathew B , Rauf A , Rengasamy KRR , Sobarzo-Sanchez E , Ashraf GM , Aleya L
Ref : Molecules , 25 :1267 , 2020
Abstract : Uddin_2020_Molecules_25_1267
ESTHER : Uddin_2020_Molecules_25_1267
PubMedSearch : Uddin_2020_Molecules_25_1267
PubMedID: 32168835

Title : Inhibitors of Monoamine Oxidase and Acetylcholinesterase as a Front Runner in CNS Drug Discovery -
Author(s) : Mathew B , Kim H
Ref : Comb Chem High Throughput Screen , 23 :834 , 2020
PubMedID: 33357175

Title : Privileged Pharmacophore of FDA Approved Drugs in Combination with Chalcone Framework: A New Hope for Alzheimer's Treatment - Mathew_2020_Comb.Chem.High.Throughput.Screen__
Author(s) : Mathew B
Ref : Comb Chem High Throughput Screen , : , 2020
Abstract : Mathew_2020_Comb.Chem.High.Throughput.Screen__
ESTHER : Mathew_2020_Comb.Chem.High.Throughput.Screen__
PubMedSearch : Mathew_2020_Comb.Chem.High.Throughput.Screen__
PubMedID: 32723232

Title : Selected 1,3-Benzodioxine-Containing Chalcones as Multipotent Oxidase and Acetylcholinesterase Inhibitors - Jeong_2020_ChemMedChem_15_2257
Author(s) : Jeong GS , Kaipakasseri S , Lee SR , Marraiki N , Batiha GE , Dev S , Palakkathondi A , Kavully FS , Gambacorta N , Nicolotti O , Mathew B , Kim H
Ref : ChemMedChem , 15 :2257 , 2020
Abstract : Jeong_2020_ChemMedChem_15_2257
ESTHER : Jeong_2020_ChemMedChem_15_2257
PubMedSearch : Jeong_2020_ChemMedChem_15_2257
PubMedID: 32924264

Title : Development of methylthiosemicarbazones as new reversible monoamine oxidase-B inhibitors for the treatment of Parkinson's disease - Mathew_2020_J.Biomol.Struct.Dyn__1
Author(s) : Mathew GE , Oh JM , Mohan K , Tengli A , Mathew B , Kim H
Ref : J Biomol Struct Dyn , :1 , 2020
Abstract : Mathew_2020_J.Biomol.Struct.Dyn__1
ESTHER : Mathew_2020_J.Biomol.Struct.Dyn__1
PubMedSearch : Mathew_2020_J.Biomol.Struct.Dyn__1
PubMedID: 32588753

Title : TV 3326 for Alzheimer's dementia: a novel multimodal ChE and MAO inhibitors to mitigate Alzheimer's-like neuropathology - Uddin_2020_J.Pharm.Pharmacol__
Author(s) : Uddin S , Kabir T , Rahman M , Mathew B , Shah MA , Ashraf GM
Ref : J Pharm Pharmacol , : , 2020
Abstract : Uddin_2020_J.Pharm.Pharmacol__
ESTHER : Uddin_2020_J.Pharm.Pharmacol__
PubMedSearch : Uddin_2020_J.Pharm.Pharmacol__
PubMedID: 32149402

Title : Exploring the Multifunctional Neuroprotective Promise of Rasagiline Derivatives for Multi-Dysfunctional Alzheimer's Disease - Uddin_2020_Curr.Pharm.Des__
Author(s) : Uddin MS , Kabir MT , Rahman MH , Alim MA , Rahman MM , Khatkar A , Al Mamun A , Rauf A , Mathew B , Ashraf GM
Ref : Curr Pharm Des , : , 2020
Abstract : Uddin_2020_Curr.Pharm.Des__
ESTHER : Uddin_2020_Curr.Pharm.Des__
PubMedSearch : Uddin_2020_Curr.Pharm.Des__
PubMedID: 32250219

Title : Novel Class of Chalcone Oxime Ethers as Potent Monoamine Oxidase-B and Acetylcholinesterase Inhibitors - Oh_2020_Molecules_25_
Author(s) : Oh JM , Rangarajan TM , Chaudhary R , Singh RP , Singh M , Tondo AR , Gambacorta N , Nicolotti O , Mathew B , Kim H
Ref : Molecules , 25 : , 2020
Abstract : Oh_2020_Molecules_25_
ESTHER : Oh_2020_Molecules_25_
PubMedSearch : Oh_2020_Molecules_25_
PubMedID: 32443652

Title : (Hetero-)(arylidene)arylhydrazides as Multitarget-Directed Monoamine Oxidase Inhibitors - Palakkathondi_2020_ACS.Comb.Sci_22_592
Author(s) : Palakkathondi A , Oh JM , Dev S , Rangarajan TM , Kaipakasseri S , Kavully FS , Gambacorta N , Nicolotti O , Kim H , Mathew B
Ref : ACS Comb Sci , 22 :592 , 2020
Abstract : Palakkathondi_2020_ACS.Comb.Sci_22_592
ESTHER : Palakkathondi_2020_ACS.Comb.Sci_22_592
PubMedSearch : Palakkathondi_2020_ACS.Comb.Sci_22_592
PubMedID: 33047950

Title : Emerging therapeutic potentials of dual-acting MAO and AChE inhibitors in Alzheimer's and Parkinson's diseases - Mathew_2019_Arch.Pharm.(Weinheim)__e1900177
Author(s) : Mathew B , Parambi DGT , Mathew GE , Uddin MS , Inasu ST , Kim H , Marathakam A , Unnikrishnan MK , Carradori S
Ref : Arch Pharm (Weinheim) , :e1900177 , 2019
Abstract : Mathew_2019_Arch.Pharm.(Weinheim)__e1900177
ESTHER : Mathew_2019_Arch.Pharm.(Weinheim)__e1900177
PubMedSearch : Mathew_2019_Arch.Pharm.(Weinheim)__e1900177
PubMedID: 31478569

Title : Cholinesterase Inhibitory Activities of Selected Halogenated Thiophene Chalcones - Parambi_2019_Cent.Nerv.Syst.Agents.Med.Chem_19_67
Author(s) : Parambi DGT , Aljoufi F , Murugaiyah V , Mathew GE , Dev S , Lakshminarayanan B , Hendawy OM , Mathew B
Ref : Cent Nerv Syst Agents Med Chem , 19 :67 , 2019
Abstract : Parambi_2019_Cent.Nerv.Syst.Agents.Med.Chem_19_67
ESTHER : Parambi_2019_Cent.Nerv.Syst.Agents.Med.Chem_19_67
PubMedSearch : Parambi_2019_Cent.Nerv.Syst.Agents.Med.Chem_19_67
PubMedID: 30451121

Title : Potent and highly selective dual-targeting monoamine oxidase-B inhibitors: Fluorinated chalcones of morpholine versus imidazole - Mathew_2019_Arch.Pharm.(Weinheim)__e1800309
Author(s) : Mathew B , Baek SC , Thomas Parambi DG , Lee JP , Mathew GE , Jayanthi S , Vinod D , Rapheal C , Devikrishna V , Kondarath SS , Uddin MS , Kim H
Ref : Arch Pharm (Weinheim) , :e1800309 , 2019
Abstract : Mathew_2019_Arch.Pharm.(Weinheim)__e1800309
ESTHER : Mathew_2019_Arch.Pharm.(Weinheim)__e1800309
PubMedSearch : Mathew_2019_Arch.Pharm.(Weinheim)__e1800309
PubMedID: 30663112

Title : Perspective Design of Chalcones for the Management of CNS Disorders: A Mini-Review - Mathew_2019_CNS.Neurol.Disord.Drug.Targets_18_432
Author(s) : Mathew B , Parambi DGT , Sivasankarapillai VS , Uddin MS , Suresh J , Mathew GE , Joy M , Marathakam A , Gupta SV
Ref : CNS Neurol Disord Drug Targets , 18 :432 , 2019
Abstract : Mathew_2019_CNS.Neurol.Disord.Drug.Targets_18_432
ESTHER : Mathew_2019_CNS.Neurol.Disord.Drug.Targets_18_432
PubMedSearch : Mathew_2019_CNS.Neurol.Disord.Drug.Targets_18_432
PubMedID: 31187716

Title : Ethyl Acetohydroxamate Incorporated Chalcones: Unveiling a Novel Class of Chalcones for Multitarget Monoamine Oxidase-B Inhibitors Against Alzheimer's Disease - Reeta_2019_CNS.Neurol.Disord.Drug.Targets_18_643
Author(s) : Reeta , Baek SC , Lee JP , Rangarajan TM , Ayushee , Singh RP , Singh M , Mangiatordi GF , Nicolotti O , Kim H , Mathew B
Ref : CNS Neurol Disord Drug Targets , 18 :643 , 2019
Abstract : Reeta_2019_CNS.Neurol.Disord.Drug.Targets_18_643
ESTHER : Reeta_2019_CNS.Neurol.Disord.Drug.Targets_18_643
PubMedSearch : Reeta_2019_CNS.Neurol.Disord.Drug.Targets_18_643
PubMedID: 31550216

Title : Cholinesterase Inhibitors for Alzheimer's Disease: Multitargeting Strategy Based on Anti-Alzheimer's Drugs Repositioning - Kabir_2019_Curr.Pharm.Des_25_3519
Author(s) : Kabir MT , Uddin MS , Begum MM , Thangapandiyan S , Rahman MS , Aleya L , Mathew B , Ahmed M , Barreto GE , Ashraf GM
Ref : Curr Pharm Des , 25 :3519 , 2019
Abstract : Kabir_2019_Curr.Pharm.Des_25_3519
ESTHER : Kabir_2019_Curr.Pharm.Des_25_3519
PubMedSearch : Kabir_2019_Curr.Pharm.Des_25_3519
PubMedID: 31593530

Title : Selected aryl thiosemicarbazones as a new class of multi-targeted monoamine oxidase inhibitors - Mathew_2018_Medchemcomm_9_1871
Author(s) : Mathew B , Baek SC , Grace Thomas Parambi D , Pil Lee J , Joy M , Annie Rilda PR , Randev RV , Nithyamol P , Vijayan V , Inasu ST , Mathew GE , Lohidakshan KK , Kumar Krishnan G , Kim H
Ref : Medchemcomm , 9 :1871 , 2018
Abstract : Mathew_2018_Medchemcomm_9_1871
ESTHER : Mathew_2018_Medchemcomm_9_1871
PubMedSearch : Mathew_2018_Medchemcomm_9_1871
PubMedID: 30568755